282 related articles for article (PubMed ID: 32595503)
1. Exploration of Oxygen-Induced Retinopathy Model to Discover New Therapeutic Drug Targets in Retinopathies.
Vähätupa M; Järvinen TAH; Uusitalo-Järvinen H
Front Pharmacol; 2020; 11():873. PubMed ID: 32595503
[TBL] [Abstract][Full Text] [Related]
2. SWATH-MS Proteomic Analysis of Oxygen-Induced Retinopathy Reveals Novel Potential Therapeutic Targets.
Vähätupa M; Nättinen J; Jylhä A; Aapola U; Kataja M; Kööbi P; Järvinen TAH; Uusitalo H; Uusitalo-Järvinen H
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3294-3306. PubMed ID: 30025079
[TBL] [Abstract][Full Text] [Related]
3. Proteomics Analysis of R-Ras Deficiency in Oxygen Induced Retinopathy.
Vähätupa M; Nättinen J; Aapola U; Uusitalo-Järvinen H; Uusitalo H; Järvinen TAH
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175621
[TBL] [Abstract][Full Text] [Related]
4. Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR).
Vähätupa M; Salonen N; Uusitalo-Järvinen H; Järvinen TAH
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834347
[TBL] [Abstract][Full Text] [Related]
5. VEGF-Trap Modulates Retinal Inflammation in the Murine Oxygen-Induced Retinopathy (OIR) Model.
Rojo Arias JE; Englmaier VE; Jászai J
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203414
[TBL] [Abstract][Full Text] [Related]
6. VEGF-Trap is a potent modulator of vasoregenerative responses and protects dopaminergic amacrine network integrity in degenerative ischemic neovascular retinopathy.
Rojo Arias JE; Economopoulou M; Juárez López DA; Kurzbach A; Au Yeung KH; Englmaier V; Merdausl M; Schaarschmidt M; Ader M; Morawietz H; Funk RHW; Jászai J
J Neurochem; 2020 May; 153(3):390-412. PubMed ID: 31550048
[TBL] [Abstract][Full Text] [Related]
7. Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy.
Kermorvant-Duchemin E; Sapieha P; Sirinyan M; Beauchamp M; Checchin D; Hardy P; Sennlaub F; Lachapelle P; Chemtob S
Doc Ophthalmol; 2010 Feb; 120(1):51-60. PubMed ID: 19882183
[TBL] [Abstract][Full Text] [Related]
8. Lack of R-Ras Leads to Increased Vascular Permeability in Ischemic Retinopathy.
Vähätupa M; Prince S; Vataja S; Mertimo T; Kataja M; Kinnunen K; Marjomäki V; Uusitalo H; Komatsu M; Järvinen TA; Uusitalo-Järvinen H
Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4898-4909. PubMed ID: 27654416
[TBL] [Abstract][Full Text] [Related]
9. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
Han N; Xu H; Yu N; Wu Y; Yu L
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
[TBL] [Abstract][Full Text] [Related]
10. Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration.
Huang H; Van de Veire S; Dalal M; Parlier R; Semba RD; Carmeliet P; Vinores SA
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7565-73. PubMed ID: 21873682
[TBL] [Abstract][Full Text] [Related]
11. Retinopathy of prematurity shows alterations in Vegfa
Mezu-Ndubuisi OJ; Song YS; Macke E; Johnson H; Nwaba G; Ikeda A; Sheibani N
Pediatr Res; 2022 Jun; 91(7):1677-1685. PubMed ID: 34285351
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
[TBL] [Abstract][Full Text] [Related]
13. [Pathological role of apelin in angiogenic eye disease].
Kasai A
Yakugaku Zasshi; 2011; 131(8):1201-6. PubMed ID: 21804324
[TBL] [Abstract][Full Text] [Related]
14. Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy.
Dai C; Waduge P; Ji L; Huang C; He Y; Tian H; Zuniga-Sanchez E; Bhatt A; Pang IH; Su G; Webster KA; Li W
Cell Mol Life Sci; 2022 Jan; 79(1):63. PubMed ID: 35006382
[TBL] [Abstract][Full Text] [Related]
15. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
16. Beta-lapachone inhibits pathological retinal neovascularization in oxygen-induced retinopathy via regulation of HIF-1α.
Park SW; Kim JH; Kim KE; Jeong MH; Park H; Park B; Suh YG; Park WJ; Kim JH
J Cell Mol Med; 2014 May; 18(5):875-84. PubMed ID: 24533641
[TBL] [Abstract][Full Text] [Related]
17. Triciribine attenuates pathological neovascularization and vascular permeability in a mouse model of proliferative retinopathy.
Shan S; Liu F; Ford E; Caldwell RB; Narayanan SP; Somanath PR
Biomed Pharmacother; 2023 Jun; 162():114714. PubMed ID: 37080089
[TBL] [Abstract][Full Text] [Related]
18. Periostin and tenascin-C interaction promotes angiogenesis in ischemic proliferative retinopathy.
Kubo Y; Ishikawa K; Mori K; Kobayashi Y; Nakama T; Arima M; Nakao S; Hisatomi T; Haruta M; Sonoda KH; Yoshida S
Sci Rep; 2020 Jun; 10(1):9299. PubMed ID: 32518264
[TBL] [Abstract][Full Text] [Related]
19. Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway.
Zhao K; Jiang Y; Zhang J; Shi J; Zheng P; Yang C; Chen Y
Cell Cycle; 2022 Oct; 21(19):2091-2108. PubMed ID: 35695424
[TBL] [Abstract][Full Text] [Related]
20. Therapies targeting Frizzled-7/β-catenin pathway prevent the development of pathological angiogenesis in an ischemic retinopathy model.
Bats ML; Bougaran P; Peghaire C; Gueniot F; Abelanet A; Chan H; Séguy C; Jeanningros S; Jaspard-Vinassa B; Couffinhal T; Duplàa C; Dufourcq P
FASEB J; 2020 Jan; 34(1):1288-1303. PubMed ID: 31914666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
